Vanguard Group’s Pasithea Therapeutics KTTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$38.7K Buy
2023
Q3
Sell
2023
Q2
$59.3K Sell
2023
Q1
$60.1K Hold
2022
Q4
$103K Buy
2022
Q3
$201K Buy
2022
Q2
$79K Buy
2022
Q1
$74K Buy
2021
Q4
$22K Buy